regeneron
Sleepy Hollow, NY
Regeneron is a global leader and pioneer in ophthalmology research and has market-leading drugs for the treatment of retinal diseases. The Eylea brand is approved for the treatment of several retinal disorders and is the market category leader in the anti-vascular endothelial growth factor (anti-VEGF) class for these disorders. Beyond Eylea, Regeneron is committed to research with other mechanisms of actions and modalities for the treatment of a variety of other ophthalmological disorders. Regeneron Global Medical Affairs is organized in an optimally aligned matrix structure for the delivery of therapeutic and functional area expertise. Our medical affairs physicians and scientists are experts on our medicines and form an extremely valuable part of our global development organization. They serve as important contacts between Regeneron and the scientific and healthcare community. The Head of Medical Affairs for Ophthalmology will report to the Head of Internal Medicine for...